University Hospitals Urology Institute

Join the Webinar -- Improving urinary incontinence care in primary care settings is crucial for enhancing patient outcomes. Join us on November 14th at 2:30 PM EST for an in-depth look at how AHRQ’s EvidenceNOW initiative is helping primary care providers implement effective, nonsurgical interventions. This webinar will share practical strategies, challenges, and solutions directly from front-line implementers, including UH’s Division Chief and Chair of Family Medicine, Goutham Rao MD,?and Urology Institute’s Research Nurse, Grace Pelfrey BSN RN.?Goutham Rao Grace Pelfrey Register now to participate! https://lnkd.in/efVT87rN

We’re #hiring a new Clinical Research Coordinator in Cleveland, Ohio. Apply today or share this post with your network.

Come join us for our next symposium and learn the tools to tell your patients: Cancer Does Not Cancel Sex

In an episode of Micro Moments with Peter, host and UH Chief Quality and Clinical Transformation Officer, Peter Pronovost MD, PhD, FCCM, Veale Distinguished Chair in Leadership and Clinical Transformation, invited guest Randy Vince Jr., MD,?a UH urologist and Director of Minority Men's Health at UH Cutler Center for Men, to join him in a discussion on addressing health disparities, how important it is to acknowledge the problem and how harnessing the power of love and collaboration can create lasting change. Listen in as Dr. Vince explains how uniting as a team and family is vital in tackling inequities and achieving rapid progress and how his approach aims to turn the tide on disparities and foster a healthier, more equitable future. Tune in here: https://lnkd.in/dE_cKexE #healthdisparities #healthequity #leadingwithlove #socialdisparitiesofhealth

Prostate cancer is the second-leading cause of cancer death among American men. Jonathan Shoag, MD, a board-certified urologist at UH Urologic Institute, is working to better understand how aging-related diseases such as prostate cancer develop – and to find better therapies. A focus of his work is understanding why some people develop diseases of aging, while others do not. “We are looking to understand the mechanisms underlying disease predisposition, as well as what factors modify this process, using the latest advances in DNA sequencing technologies,” he says. “The National Institutes of Health has awarded my group, along with collaborators at NYU, an R01 grant to further this area of study.” In addition, Shany Picciotto, PhD, a postdoc in Dr. Shoag’s lab, has received a Research Scholar Award from the American Urological Association – one of only 15 researchers in the U.S. to do so. Dr. Picciotto will conduct a two-year study of how chemotherapy impacts mutation burden in normal cells and how this may impact mutations in the children of cancer survivors. Dr. Shoag is also working to develop more effective therapies against prostate cancer. He received a $1.1 million Physician Research Grant from the Congressionally Directed Medical Research Program of the U.S. Department of Defense – one of only six researchers in the country to receive this grant for fiscal year 2024. “My lab leveraged large-scale clinical data to discover a new target in prostate cancer,” Dr. Shoag says. “This grant will support understanding this target in mice, cells and patient-derived prostate cancer models?to help us better understand prostate cancer biology and ultimately develop better therapies, which will benefit patients with advanced disease.” Read more at https://lnkd.in/gpsPu-Ed #prostatecancer #NIH #research #physicianexcellence #patientsfirst

On Saturday, November 16, join Rachel Pope MD, MPH & University Hospitals Female Sexual Health (FSH) Team for their annual FSH Symposium! Gain valuable knowledge and practical strategies to support your patients in navigating the complexities of sexual health during and after cancer treatment. Earn #CME (provided by The MetroHealth System (Cleveland, OH)) by listening to expert speakers share the latest research, clinical approaches, real-life stories and patient-centered techniques to enhance the quality of life for women facing cancer. For #Gynecologists, #Urologists, #APPs, #PrimaryCareProviders, #Internists, #PhysicalTherapists, #Psychologists & More Learn more & register via the link below! https://lnkd.in/ePaFfQ7b

This fall, University Hospitals Urology Institute is proud to present two educational opportunities for clinicians interested in #PediatricUrology & #FemaleSexualHealth. On Friday, September 20, join Drs. Pedro-José López, Juan Moldes & the Pediatric Urology Team from UH Rainbow Babies and Children's Hospital for their 'Pediatric Urology Course.' Geared toward #Pediatricians, #FamilyDoctors, #FamilyNursePractitioners, #PediatricNursePractitioners and #GeneralPractitioners, this course features discussion of the most common pediatric urology pathologies seen in daily clinics, based on real clinical cases. On Saturday, November 16, find Rachel Pope MD, MPH & University Hospitals Urology Institute's Female Sexual Health Team at their annual FSH Symposium. 'Cancer Does Not Cancel Sex: A Gude to Help Your Female Patients Survive & Thrive' will give #Gynecologists, #Urologists, #APPs, #PrimaryCareProviders, #Internists, #PhysicalTherapists and #Psychologists valuable knowledge and practical strategies to support patients navigating the complexities of sexual health during and after cancer treatment. Learn more & register for both of these events via the links below! https://lnkd.in/exMFhhBK https://lnkd.in/ePaFfQ7b

Prostate enlargement is common in men over 50 and can lead to urinary dysfunction as well as bladder or kidney problems. Historically, there wasn’t much that could be done, and even treatments developed a century ago were often complicated. Recovery could last several weeks, with the patient enduring restrictions and discomfort during that time. Thankfully, today there are other options to deal with enlarged prostates. At UH, patients of urologic surgeon Michael Zell, MD, are often surprised at how simple and efficient the procedure can be, with the patient frequently being discharged the same day, and recovery lasting only a few days more. Dr. Zell, along with Dr. Irina Jaeger, are among just a few surgeons in Ohio, and a very small percentage of surgeons in the country, who perform the HoLEP (holmium laser enucleation of the prostate) procedure, and among even fewer surgeons who perform it with great frequency. HoLEP requires no incision. Surgical entry is through the urethra, and whether the prostate is small or very large is irrelevant, and then the extremely precise holmium laser is used to cut through the prostate. Almost all of these procedures are done on an outpatient basis, and the patient returns for catheter removal within 24 to 48 hours, with a quick return to normal function. Patients tell Dr. Zell how quickly their lives changed post-op. “It’s like night and day,” they’ll say. For months and years, they had suffered with complications that occur when the enlarged prostate interferes with bladder function. “Seeing patients get better is the most rewarding part for all of us,” Dr. Zell says. Read more about Dr. Zell at https://lnkd.in/gGv9pGYy #enlargedprostate #BPH #HoLEP #physicianexcellence #patientsfirst

This September, our University Hospitals Rainbow Babies & Children's Pediatric Urology team is hosting a best-in-class course reviewing common urologic pathologies seen by pediatricians & family medicine clinicians. Discuss & review real cases for an enhanced understanding of this specialty field. Join us in Cleveland / help us spread the word for this fantastic educational & social event! ?? ?? https://lnkd.in/exMFhhBK